Ginkgo Bioworks

The European Medicines Agency's Committee for Orphan Medicinal Products issued a positive opinion recommending Orphan Drug Designation for GLIX1, Hemispherian's lead molecule targeting glioma.

Regeneron Pharmaceuticals has entered a licensing agreement with Telesis Bio to deploy the Gibson SOLA platform at its R&D facilities for automated gene synthesis.

MAXIOM officially launched its AI platform that integrates DNA analysis, biomarkers, wearables, and artificial intelligence to deliver personalized health and performance guidance through conversational interactions.

Researchers at KU Leuven have developed a novel dual-agent approach that renders HIV permanently harmless by forcing the virus into a deep dormant state.

Oligo Factory has launched a new low-scale oligonucleotide synthesis capability, enabling researchers to order custom DNA and RNA oligos in volumes as small as 50 nmol while maintaining high quality standards.

• Camber Pharmaceuticals has announced the launch of Temozolomide Capsules, USP, an alkylating drug used in the treatment of glioblastoma and anaplastic astrocytoma in adults. • The medication will be available in five different strengths (5mg, 20mg, 100mg, 140mg, 180mg, and 250mg) and in various count options to support different treatment regimens. • Temozolomide is primarily used as a concurrent treatment with radiotherapy for newly diagnosed glioblastoma patients, followed by maintenance therapy, addressing critical needs in brain cancer treatment.

The MATCH clinical utility study shows that Mindera Health's Mind.Px test significantly altered physician prescribing behavior with 93.1% concordance compared to 65.4% in the control group.

Researchers at the Centre for Genomic Regulation have created an AI tool that designs synthetic DNA regulatory sequences capable of controlling gene expression in healthy mammalian cells with unprecedented precision.

Guardant Health has launched Guardant360 Tissue, the first molecular profiling test for tumor tissue that incorporates comprehensive multiomics analysis including DNA, RNA, AI-powered PD-L1 and genome-wide methylation data.

Alcohol-related deaths in the United States nearly doubled from 1999 to 2020, rising from 10.7 to 21.6 per 100,000 people, with women experiencing the largest relative increase despite men having higher overall rates.